Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis of autoimmune hepatitis.

I G McFarlane1

  • 1Institute of Liver Studies, King's College Hospital, London, United Kingdom.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|July 29, 1999
PubMed
Summary

Autoimmune hepatitis (AIH) is an idiopathic liver disease characterized by inflammation and auto-antibodies. While its exact cause is unknown, genetic predisposition and environmental triggers likely play a role in its development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoantibodies in alcoholic liver disease.

Addiction biology·2010
Same author

Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.

Alimentary pharmacology & therapeutics·2008
Same author

Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin.

Gut·2002
Same author

Autoimmune liver diseases.

Scandinavian journal of clinical and laboratory investigation. Supplementum·2001
Same author

Autoimmune hepatitis: Clinical manifestations and diagnostic criteria.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2001
Same author

Management and outcome of pregnancy in autoimmune hepatitis.

Gut·2000

Area of Science:

  • Hepatology
  • Immunology
  • Autoimmune Diseases

Background:

  • Autoimmune hepatitis (AIH) is an idiopathic inflammatory liver disease.
  • Diagnosis relies on characteristic histological findings of interface hepatitis, elevated immunoglobulins, and auto-antibodies, alongside a positive response to immunosuppression.
  • The precise pathogenetic mechanisms remain incompletely understood.

Purpose of the Study:

  • To elucidate the underlying pathogenetic mechanisms of autoimmune hepatitis.
  • To explore the interplay of genetic predisposition, immune dysregulation, and environmental factors in AIH development.
  • To understand the effector mechanisms driving liver damage in AIH.

Main Methods:

  • Review of existing literature and evidence regarding AIH pathogenesis.
  • Analysis of immunological defects and loss of self-tolerance to liver auto-antigens.
  • Consideration of potential initiating factors like viral infections or toxins.

Main Results:

  • Evidence suggests a genetic predisposition to AIH.
  • Defects in immunological control lead to a loss of self-tolerance to liver auto-antigens.
  • Environmental factors may trigger the disease in susceptible individuals.
  • Tissue damage likely results from auto-antibodies targeting hepatocyte surface antigens.

Conclusions:

  • AIH pathogenesis involves a complex interaction between genetic susceptibility and environmental triggers.
  • Loss of immune tolerance to liver auto-antigens is a key feature.
  • Auto-antibody mediated damage to hepatocytes is the probable primary mechanism of liver injury.

Related Experiment Videos